News

Stephen Senn

Moving between the UK and Switzerland, and between academia and industry has given Editorial Advisory Board member and statistician Stephen Senn a well-rounded view of pharmaceutical development.

Getting answers to the right questions can help you decide how to choose and implement an electronic system that is a good match for your company's SAE reporting needs and its available resources.

A systematic survey of 96 pharmaceutical companies and clinical research organizations revealed which systems sponsors are using for clinical data management and adverse events tracking and reporting.

CDISC has broad support for its fledgling standard whose evolution is critical to the acceleration of technology adoption in clinical trials.

Combining the principles of adult learning with the advantages of Web technology can engage participants in important investigator meetings.

New systems of ethical oversight for randomized controlled trials could ease the problems caused by increasingly cumbersome restrictions.

EN ISO/IEC 17025 is more evidence that international standards are evolving to keep pace with technology and improve the performance of accredited central laboratories.

Domenico Criscuolo

As well as being a committed European, Domenico Criscuolo is a powerful supporter of the Italian clinical research community.

A creative mobile monitoring model could help sponsors tap the potential of southern Europe (and Mexico) as areas for clinical research.

David Sabritt

Sabritt recalls the challenge of building a data management organization from the ground up while striving to retain the pioneering spirit, flexibility, and rapid decision-making capabilities or a startup culture.

Are the virtual pharmaceutcal companies created by outsourcing and today's data-sharing technologies a sign of the industry's future direction?

Guest Editorial

Let's start taking "e" for granted and look instead at the features we really need in clinical technology applications.

Conference Reports

Communication and Data Management Strategies & Sptlight falls on GCP Directive, Ethics in Paris

Affairs of State

As FDA monitors more international clinical trials, new policies aim to address differences in national approaches to such issues as placebos and protocols.